In Silico screening for agonists and blockers of the β2 adrenergic receptor: Implications of inactive and activated state structures
- 14 December 2011
- journal article
- research article
- Published by Wiley in Journal of Computational Chemistry
- Vol. 33 (5) , 561-572
Abstract
Ten crystal structures of the β2 adrenergic receptor have been published, reflecting different signaling states. Here, through controlled‐docking experiments, we examined the implications of using inactive or activated structures on the in silico screening for agonists and blockers of the receptor. Specifically, we targeted the crystal structures solved in complex with carazolol (2RH1), the neutral antagonist alprenalol, the irreversible agonist FAUC50 (3PDS), and the full agonist BI‐167017 (3P0G). Our results indicate that activated structures favor agonists over blockers, whereas inactive structures favor blockers over agonists. This tendency is more marked for activated than for inactive structures. Additionally, agonists tend to receive more favorable docking scores when docked at activated rather than inactive structures, while blockers do the opposite. Hence, the difference between the docking scores attained with an activated and an inactive structure is an excellent means for the classification of ligands into agonists and blockers as we determined through receiver operating characteristic curves and linear discriminant analysis. With respect to virtual screening, all structures prioritized well agonists and blockers over nonbinders. However, inactive structures worked better for blockers and activated structures worked better for agonists, respectively. Notably, the combination of individual docking experiments through receptor ensemble docking resulted in an excellent performance in the retrieval of both agonists and blockers. Finally, we demonstrated that the induced‐fit docking of agonists is a viable way of modifying an inactive crystal structure and bias it toward the in silico recognition of agonists rather than blockers. © 2011 Wiley Periodicals, Inc. J Comput Chem, 2011Keywords
This publication has 47 references indexed in Scilit:
- Progress in Structure Based Drug Design for G Protein-Coupled ReceptorsJournal of Medicinal Chemistry, 2011
- In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptorJournal of Molecular Graphics and Modelling, 2011
- Docking-based virtual screening for ligands of G protein-coupled receptors: Not only crystal structures but also in silico modelsJournal of Molecular Graphics and Modelling, 2011
- Conserved Binding Mode of Human β2Adrenergic Receptor Inverse Agonists and Antagonist Revealed by X-ray CrystallographyJournal of the American Chemical Society, 2010
- Structure-Based Discovery of A2AAdenosine Receptor LigandsJournal of Medicinal Chemistry, 2010
- Structure-Based Discovery of Novel Chemotypes for Adenosine A2AReceptor AntagonistsJournal of Medicinal Chemistry, 2010
- GPCR 3D homology models for ligand screening: Lessons learned from blind predictions of adenosine A2a receptor complexProteins: Structure, Function, and Bioinformatics, 2009
- Ligand and structure‐based models for the prediction of ligand‐receptor affinities and virtual screenings: Development and application to the β2‐adrenergic receptorJournal of Computational Chemistry, 2009
- Identifying conformational changes of the β2 adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulatorsJournal of Computer-Aided Molecular Design, 2009
- Discovery of New GPCR Biology: One Receptor Structure at a TimeStructure, 2009